Business
ASX 200 to rise after positive AstraZeneca COVID-19 vaccine news
It looks set to be another positive day of trade for the S&P/ASX 200 Index (ASX: XJO) on Tuesday after a third COVID-19 vaccine candidate was shown to be effective.
At the time of writing, SPI futures are pointing to the ASX opening the day 31 points or 0.5% higher this morning.
What is the new vaccine candidate?
Overnight British pharmaceutical giant AstraZeneca revealed that data from an interim analysis of clinical trials showed that its vaccine, AZD1222, had an average efficacy of 70% in protecting against COVID-19.
This follows recent updates by both Pfizer and Moderna which showed that their vaccines are 95% effective against the virus.
While 70% might not sound amazing, it is worth noting that the AstraZeneca vaccine,…
-
Noosa News22 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General21 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News23 hours agoSchoolgirls hit by fishtailing car in terrifying crash in Bellbird Park, Ipswich
-
Noosa News20 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace